Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study

Tranexamic Acid Use in Pediatric Craniotomies at a Large Tertiary Care Pediatric Hospital: A Five Year Retrospective Study

Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has proven efficacy and is recommended for major pediatric surgery to decrease perioperative blood loss. Accumulating evidence suggests that TXA reduces bleeding and transfusion in a variety of adult neurosurgical settings. However, there is...

Full description

Bibliographic Details
Main Authors: Jue T. Wang, Samir C. Seshadri, Carolyn G. Butler, Steven J. Staffa, Anna S. Kordun, Karina E. Lukovits, Susan M. Goobie
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Clinical Medicine
Subjects:
pediatrics
neurosurgery
patient blood management (PBM)
tranexamic acid
antifibrinolytics
blood loss
Online Access:https://www.mdpi.com/2077-0383/12/13/4403

Similar Items

Similar Items